BrillianceTube: Market Launch of Decorated Packaging
Sanner GmbH, a manufacturer of high-quality plastic packaging for pharmaceutical, medical and healthcare products, is expanding its portfolio. The new BrillianceTube for effervescent tablets with in-mold labeling (IML) and the proven desiccant closures offers customers a complete solution.
Photorealistic printing and more legible product information are some of the advantages of the newly launched BrillianceTube packaging from Sanner GmbH. Combined with proven Sanner desiccant closures, the tubes are best suited for effervescent tablets, but also work with conventional or coated tablets and other solid pharmaceutical products. Manufactured using IML technology, the packaging offers customers a wide range of design options and a premium-quality appearance. BrillianceTubes combined with proven Sanner desiccant closures protect their contents perfectly against light and moisture.
The advantage of IML technology is that packaging production and decoration are combined into a single process. Printed labels are placed in the mold and the liquid plastic is injected. The temperature of the plastic causes the label to fully bond with the tube. Additionally the geometry of the tube base ensures that the tubes can be easily packaged in standard commercial sales trays.
Expansion of Effervescent Packaging Product Range
"The development of Brilliance underscores our leadership position in the field of effervescent packaging. It is especially important for us to support our customers as a system supplier across the entire supply chain," explained Sanner CEO Holger Frank. This includes the systematic development of efficient logistical solutions. Sanner customers get everything from a single source: from printed labels and the manufacturing of decorated tubes up to delivery. "Our customers can always rely on proven Sanner quality. In addition, having a centrally-located contact reduces organizational effort,” Frank emphasized. "Our customers can efficiently purchase their decorated tubes with different fitting types of closures. Thus, Brilliance enables us to meet customer demands with more flexibility."
More Attention at the Point of Sale
Unlike conventional printed packaging, tubes manufactured using the IML technology offer high quality, photorealistic printing with a choice of textures and finishes. Up to eight colours and metallic effects are possible to make packaging stand out at the point of sale. Labels that are easy to read with smaller font sizes provide more space for important product information. The high-impact, scratch-resistant material is extremely durable. Using modern communication media such as integrated QR codes makes it easier for customers to access additional information about the manufacturer and product.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance